Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.

Werner BG, Snydman DR, Freeman R, Rohrer R, Tilney NL, Kirkman RL. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 2):1441-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.